Read the Initiative


Official Ballot Title & Summary of Proposition 14:

AUTHORIZES BONDS CONTINUING STEM CELL RESEARCH. INITIATIVE STATUTE.

  • Authorizes $5.5 billion in state general obligation bonds to fund grants from the California Institute for Regenerative Medicine to educational, nonprofit, and private entities for: stem cell and other medical research, including training; stem cell therapy development and delivery; research facility construction; and associated administrative expenses.

  • Dedicates $1.5 billion to research and therapy for Alzheimer’s, Parkinson’s, stroke, epilepsy, and other brain and central nervous system diseases and conditions.

  • Appropriates General Fund moneys to pay bond debt service.

  • Expands programs promoting stem cell and other medical research, therapy development and delivery, and student and physician training and fellowships.
Summary of Legislative Analyst’s Estimate of Net State and Local Government Fiscal Impact:
  • Increased state costs to repay bonds estimated at about $260 million per year over the next roughly 30 years.

OFFICIAL BALLOT ARGUMENT:

Here’s why leading doctors, scientists, and more than 80 patient advocate groups urge YES on Prop 14:


PROPOSITION 14: STEM CELL TREATMENTS, CURES, AND SAVING LIVES.
Nearly half of all California families include a child or adult with medical conditions who could benefit from Stem Cell research, treatments, and cures.

Prop. 14 provides continued funding to develop treatments, advance clinical trials and achieve new scientific breakthroughs for California’s patients with Cancer, Diabetes, Heart Disease, Alzheimer’s, Parkinson’s, HIV/AIDS, ALS, MS, Sickle Cell Disease, Lung Diseases, Kidney Disease, Bubble Baby Disease, Age-Related Blindness and Genetic Blindness, Epilepsy, Stroke, Schizophrenia, Autism, other Mental Health and Brain Conditions, and Infectious Diseases like COVID-19.

BUILDING ON CONTINUING SUCCESS: 92 FDA-APPROVED CLINICAL TRIALS / 2,900 MEDICAL DISCOVERIES TO DATE.
California’s original Stem Cell funding, which runs out this year, has already led to significant progress in the development of treatments and cures, including 92 FDA approved clinical trials for chronic disease and injuries, over 2,900 medical discoveries, and demonstrated benefits for patients and research on chronic diseases including: Cancer, Diabetes, Heart Conditions, Blindness, HIV/AIDS, ALS, Children with Immune Deficiencies, Paralysis, and Kidney Disease.

SUCCESS STORIES OF CALIFORNIA PATIENTS TREATED INCLUDE:
  • A high school student paralyzed in a diving accident has regained upper body function.

  • A mother blinded by a genetic disease is regaining her eyesight.

  • A cure was discovered for a fatal disease that causes children to be born without functioning immune systems.

  • FDA-approved treatments for two types of fatal blood cancers. Hear from more patients at www.YESon14.com/successes

SUPPORTED BY OVER 80 PATIENT ADVOCATE ORGANIZATIONS.
YES vote on Prop. 14 is endorsed by the University of California, NOBEL PRIZE WINNERS, leading patient and medical science advocates, and more than 80 PATIENT ADVOCATE ORGANIZATIONS, including:

American Association for Cancer Research • American Diabetes Association • Leukemia & Lymphoma Society • Juvenile Diabetes Research Foundation • The Michael J. Fox Foundation for Parkinson’s Research • ALS Association, Golden West Chapter • CURE—Citizens United for Research in Epilepsy • One Mind • Immune Deficiency Foundation • Women’s Alzheimer’s Movement • Alzheimer’s Los Angeles • Christopher & Dana Reeve Foundation for Paralysis • Cystic Fibrosis Research, Inc. • Arthritis Foundation • Sickle Cell Disease Foundation of California • Foundation for Fighting Blindness • San Francisco AIDS Foundation

“Prop. 14 builds on California’s progress to date, helping to accelerate medical breakthroughs out of the lab and into clinical trials, where they can help improve and save patient lives.”—Dr. Adriana Padilla, Fresno

INCREASES PATIENT ACCESS & AFFORDABILITY.
Dedicates “The Treatment and Cures Accessibility and Affordability Working Group” experts to dramatically expand access to clinical trials and new therapies, make treatments and cures more affordable for Californians, and provide patients, their families, and caregivers with financial assistance.

ECONOMIC AND JOBS RECOVERY STIMULUS.
New revenues, economic activity and jobs are generated by this funding that will contribute to California’s economic recovery. There are no State bond payments during the first five years; and, supporting California’s Stem Cell program will only cost the State an average of less than $5 per person annually.

ENSURES STRICT ACCOUNTABILITY & TRANSPARENCY.
California’s Controller chairs The Citizens Financial Accountability Oversight Committee, which reviews independent, financial, and performance audits, of the funding Institute. The Institute complies with California’s Open Meeting Act, Public Records Act, and Political Reform Act.

Chronic diseases, conditions and injuries are cutting lives short, and costing Californians billions in healthcare costs. We must continue our investment, developing Stem Cell treatments to improve the health and reduce the suffering of millions of Californians.

VOTE YES ON 14. IT COULD SAVE YOUR LIFE OR THE LIFE OF SOMEONE YOU LOVE. www.YESon14.com

ANTONI RIBAS, M.D., Ph.D., President
American Association for Cancer Research

CYNTHIA E. MUÑOZ, Ph.D., MPH, President
American Diabetes Association-Los Angeles

ROBERT A. HARRINGTON, M.D., Chairman
Department of Medicine, Stanford University

Titles & affiliations are for identification purposes only